Low magnesium is not a significant predictor of hard events in acute myocardial infarction.

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet (1995) 7.97

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet (1992) 3.40

Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr (2013) 1.54

Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (1998) 1.46

Dietary and serum magnesium levels in patients with acute myocardial infarction, coronary artery disease and noncardiac diagnoses. J Am Coll Nutr (1994) 1.40

Hypomagnesemia. J Am Soc Nephrol (1999) 1.38

Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol (2005) 1.37

Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology (2006) 1.36

Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis (2011) 1.19

Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet (2002) 1.14

Magnesium and cardiovascular system. Magnes Res (2010) 1.10

Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol (1999) 1.07

Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. Am Heart J (2010) 1.00

Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Am Heart J (2000) 0.97

The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care (2002) 0.96

Dietary and plasma magnesium and risk of coronary heart disease among women. J Am Heart Assoc (2013) 0.91

Intracellular and extracellular blood magnesium fractions in hemodialysis patients; is the ionized fraction a measure of magnesium excess? Clin Chem (1998) 0.91

Elevated levels of oxidative stress as a prognostic predictor of major adverse cardiovascular events in patients with coronary artery disease. J Atheroscler Thromb (2012) 0.90

Role of magnesium in cardiovascular diseases. Cardiol Rev (2014) 0.89

The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. J Am Coll Nutr (1995) 0.88

Individual and summed effects of high-risk genetic polymorphisms on recurrent cardiovascular events following ischemic heart disease. Atherosclerosis (2012) 0.84

The prospect of serum magnesium and an electrolyte panel as an adjuvant cardiac biomarker in the management of acute myocardial infarction. J Clin Diagn Res (2013) 0.84

Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarction. PLoS One (2014) 0.81

Challenges of LADA Diagnosis and Treatment: Lessons From 2 Case Reports. Am J Ther (2016) 0.75